Skip to content

BRAIN Act

In committee: it can still change before the session ends.

US HR 2767 · House Bill · 119th Congress

Stage
In committee
Started in
House
Sponsors
76
Latest action
Apr 9, 2025

What it does

The BRAIN Act aims to advance brain tumor research and improve patient care by establishing a Glioblastoma Therapeutics Network and funding for cellular immunotherapy research, creating a public biospecimen reporting system, launching a national awareness campaign on cancer clinical trials and biomarker testing, and supporting pilot programs for brain tumor survivor care. It affects researchers, healthcare providers, patients, and entities handling NIH-funded brain tumor biospecimens, requiring transparency in biospecimen collections and oversight for noncompliance. The bill authorizes specific annual appropriations from 2026 to 2030 for these initiatives, including $50 million for the…

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Apr 9, 2025

  2. Committee (Current step)

    In committee · Apr 9, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

BRAIN Act | 52